SCHEMBL30381089

SCHEMBL30381089

CCOC(=O)c1cc(N)cc(C2=CCOCC2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.45
▸ LMNA P02545 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ MAOA P21397 1/20 0.41
▸ CA12 O43570 2/20 0.39
▸ CA1 P00915 2/20 0.39
▸ CA2 P00918 2/20 0.39
▸ CA7 P43166 2/20 0.39
▸ CA9 Q16790 2/20 0.39
▸ CA14 Q9ULX7 2/20 0.39
▸ ATAD2 Q6PL18 1/20 0.37
▸ PIK3CA P42336 3/20 0.36
▸ PIK3CD O00329 2/20 0.35
▸ SYK P43405 1/20 0.35
▸ BRD4 O60885 1/20 0.35
▸ BRD2 P25440 1/20 0.35
▸ CREBBP Q92793 1/20 0.35
▸ FABP7 O15540 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29858668 0.86 ATAD2 (0.47) LMNACA12CA1CA2CA7
SCHEMBL2810136 0.73 NPC1 (0.68) NPC1LMNACYP1A2CYP3A4MAOA
SCHEMBL1278720 0.73 NPC1 (0.68) NPC1LMNACYP1A2CYP3A4MAOA
Hydrochloric Acid SCHEMBL9156219 0.72 NPC1 (0.66) NPC1LMNACYP1A2CYP3A4MAOA
SCHEMBL31398152 0.71 MAPK14 (0.41) CYP3A4PIK3CAPIK3CDFABP7SMN1; SMN2
SCHEMBL20657452 0.71 KDM4E (0.38) NPC1CYP1A2PIK3CAPIK3CDRAB9A
SCHEMBL4155667 0.70 NPC1 (0.47) NPC1LMNACYP1A2CYP3A4MAOA
SCHEMBL30730411 0.69 LIPE (0.46) NPC1LMNAPIK3CAPIK3CDBRD4
SCHEMBL30730345 0.69 PIK3CA (0.40) PIK3CAPIK3CDBRD4FABP7ELANE
SCHEMBL584117 0.69 NPC1 (0.62) NPC1LMNACYP1A2CYP3A4MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023060173-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF USE AQUINNAH PHARMACEUTICALS, INC. (US) 2023-04-13 — — WO disclosed
Send feedback